| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |